BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19631208)

  • 1. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha.
    Madonna R; Shelat H; Xue Q; Willerson JT; De Caterina R; Geng YJ
    Exp Cell Res; 2009 Oct; 315(17):2921-8. PubMed ID: 19631208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells.
    Pregi N; Wenker S; Vittori D; Leirós CP; Nesse A
    Exp Cell Res; 2009 Feb; 315(3):419-31. PubMed ID: 19056379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
    Kin H; Wang NP; Mykytenko J; Reeves J; Deneve J; Jiang R; Zatta AJ; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Shock; 2008 Jun; 29(6):761-8. PubMed ID: 18496137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.
    Kewalramani G; Puthanveetil P; Wang F; Kim MS; Deppe S; Abrahani A; Luciani DS; Johnson JD; Rodrigues B
    Cardiovasc Res; 2009 Oct; 84(1):42-53. PubMed ID: 19477967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases.
    Wilms H; Schwabedissen B; Sievers J; Lucius R
    J Neuroimmunol; 2009 Jul; 212(1-2):106-11. PubMed ID: 19464738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts.
    Ling S; Luo R; Dai A; Guo Z; Guo R; Komesaroff PA
    Phytomedicine; 2009 Jan; 16(1):56-64. PubMed ID: 19010649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.
    Madonna R; Geng YJ; Bolli R; Rokosh G; Ferdinandy P; Patterson C; De Caterina R
    J Biol Chem; 2014 Jul; 289(28):19585-98. PubMed ID: 24855642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.
    Bogoyevitch MA
    Cardiovasc Res; 2004 Aug; 63(2):208-16. PubMed ID: 15249178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
    Wu H; Dong G; Liu H; Xu B; Li D; Jing H
    Eur J Pharmacol; 2009 Jan; 602(2-3):406-12. PubMed ID: 19061883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin reduces lipopolysaccharide-induced cell Damage and midkine secretion in U937 human histiocytic lymphoma cells.
    Yazihan N; Karakurt O; Ataoglu H
    Adv Ther; 2008 May; 25(5):502-14. PubMed ID: 18465096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin.
    van Tuyn J; Knaän-Shanzer S; van de Watering MJ; de Graaf M; van der Laarse A; Schalij MJ; van der Wall EE; de Vries AA; Atsma DE
    Cardiovasc Res; 2005 Aug; 67(2):245-55. PubMed ID: 15907818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
    Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Khai NC; Maruyama R; Ogino A; Minatoguchi S; Fujiwara T; Fujiwara H
    Circulation; 2006 Jan; 113(4):535-43. PubMed ID: 16449733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response.
    Moresi V; Pristerà A; Scicchitano BM; Molinaro M; Teodori L; Sassoon D; Adamo S; Coletti D
    Stem Cells; 2008 Apr; 26(4):997-1008. PubMed ID: 18258721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
    J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants.
    Mir M; Asensio VJ; Tolosa L; Gou-Fabregas M; Soler RM; Lladó J; Olmos G
    Neuroscience; 2009 Sep; 162(4):959-71. PubMed ID: 19477238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?
    Chanséaume S; Azarnoush K; Maurel A; Bellamy V; Peyrard S; Bruneval P; Hagège AA; Menasché P
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):293-7. PubMed ID: 17669846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in cardiac myocytes during the early stage after severe burn.
    Zhang JP; Ying X; Liang WY; Luo ZH; Yang ZC; Huang YS; Wang WC
    J Trauma; 2008 Aug; 65(2):401-8; discussion 408. PubMed ID: 18695479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
    Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
    Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.